[Examination of the effect of anesthesia on radiofrequency ablation of hepatocellular carcinoma-a patient survey on anesthesia for radiofrequency ablation]
- PMID: 23267905
[Examination of the effect of anesthesia on radiofrequency ablation of hepatocellular carcinoma-a patient survey on anesthesia for radiofrequency ablation]
Abstract
Purpose: Radiofrequency ablation(RFA) is minimally invasive and is easy to perform. In the RFA procedure, puncture and passing of the electrical current are painful. Therefore, some facilities use general anesthesia for RFA. In order to evaluate the use of general anesthesia for RFA of hepatocellular carcinoma, a questionnaire survey was conducted.
Methods: With the cooperation of Tokyo liver-tomo-no-kai(Tokyo Liver Association), a questionnaire survey was conducted for patients who underwent RFA. In the survey, data on the following were obtained "type of anesthesia used", "number of RFA treatment points", "duration of treatment", "length of impact of pain", and "if you need to receive RFA treatment again, how would you feel about this."
Results: The ratio of local anesthesia (LA) to general anesthesia (GA) was 113:24. The ratios of the numbers of patients who felt pain to those who felt no pain were 64:49 (LA) and 0:24 (GA). The ratios of the patients who wished to not receive RFA again to the patients who were comfortable with receiving RFA were 65:45 (LA) and 4:20 (GA).
Conclusion: GA achieves better pain control compared to LA, and the patients who receive GA have greater tolerance of RFA.
Similar articles
-
[Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].Zhonghua Zhong Liu Za Zhi. 2005 Oct;27(10):623-5. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438875 Clinical Trial. Chinese.
-
Factors related to postoperative pain among patients who underwent radiofrequency ablation of hepatocellular carcinoma.Clin Radiol. 2013 Jun;68(6):600-7. doi: 10.1016/j.crad.2012.12.006. Epub 2013 Jan 23. Clin Radiol. 2013. PMID: 23352765
-
Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study.Hepatogastroenterology. 2007 Jun;54(76):985-9. Hepatogastroenterology. 2007. PMID: 17629022
-
Radiofrequency ablation for malignant liver tumor.Surg Oncol. 2005 Jul;14(1):41-52. doi: 10.1016/j.suronc.2005.01.001. Surg Oncol. 2005. PMID: 15777889 Review.
-
Radiofrequency ablation of hepatocellular carcinoma.Surg Oncol Clin N Am. 2011 Apr;20(2):281-99, viii. doi: 10.1016/j.soc.2010.11.010. Surg Oncol Clin N Am. 2011. PMID: 21377584 Review.
Cited by
-
Comparison of deep and moderate neuromuscular blockade in microwave ablation of liver tumours: a randomized-controlled clinical trial.Sci Rep. 2021 Jan 27;11(1):2299. doi: 10.1038/s41598-021-81913-1. Sci Rep. 2021. PMID: 33504909 Free PMC article. Clinical Trial.
-
Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial.Trials. 2019 Jan 8;20(1):28. doi: 10.1186/s13063-018-3010-z. Trials. 2019. PMID: 30621749 Free PMC article. Clinical Trial.
-
Safety and efficacy of pentazocine-midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma.JGH Open. 2022 Jul 17;6(8):569-576. doi: 10.1002/jgh3.12788. eCollection 2022 Aug. JGH Open. 2022. PMID: 35928702 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical